| Convergent antibody responses to SARS-CoV-2 in convalescent individuals DF Robbiani, C Gaebler, F Muecksch, JCC Lorenzi, Z Wang, A Cho, ... Nature 584 (7821), 437-442, 2020 | 1955 | 2020 |
| Evolution of antibody immunity to SARS-CoV-2 C Gaebler, Z Wang, JCC Lorenzi, F Muecksch, S Finkin, M Tokuyama, ... Nature 591 (7851), 639-644, 2021 | 1643 | 2021 |
| Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses F Schmidt, Y Weisblum, F Muecksch, HH Hoffmann, E Michailidis, ... Journal of Experimental Medicine 217 (11), e20201181, 2020 | 547 | 2020 |
| Combination therapy with anti-HIV-1 antibodies maintains viral suppression P Mendoza, H Gruell, L Nogueira, JA Pai, AL Butler, K Millard, ... Nature 561 (7724), 479-484, 2018 | 458 | 2018 |
| Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination A Cho, F Muecksch, D Schaefer-Babajew, Z Wang, S Finkin, C Gaebler, ... Nature 600 (7889), 517-522, 2021 | 259 | 2021 |
| Persistent cellular immunity to SARS-CoV-2 infection G Breton, P Mendoza, T Hägglöf, TY Oliveira, D Schaefer-Babajew, ... Journal of Experimental Medicine 218 (4), e20202515, 2021 | 139 | 2021 |
| Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity J Niessl, AE Baxter, P Mendoza, M Jankovic, YZ Cohen, AL Butler, CL Lu, ... Nature medicine 26 (2), 222-227, 2020 | 117 | 2020 |
| Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoir C Gaebler, JCC Lorenzi, TY Oliveira, L Nogueira, V Ramos, CL Lu, JA Pai, ... Journal of Experimental Medicine 216 (10), 2253-2264, 2019 | 106 | 2019 |
| Relationship between latent and rebound viruses in a clinical trial of anti–HIV-1 antibody 3BNC117 YZ Cohen, JCC Lorenzi, L Krassnig, JP Barton, L Burke, J Pai, CL Lu, ... Journal of Experimental Medicine 215 (9), 2311-2324, 2018 | 100 | 2018 |
| Antigen-responsive CD4+ T cell clones contribute to the HIV-1 latent reservoir P Mendoza, JR Jackson, TY Oliveira, C Gaebler, V Ramos, M Caskey, ... Journal of Experimental Medicine 217 (7), 2020 | 92 | 2020 |
| Relationship between intact HIV-1 proviruses in circulating CD4+ T cells and rebound viruses emerging during treatment interruption CL Lu, JA Pai, L Nogueira, P Mendoza, H Gruell, TY Oliveira, J Barton, ... Proceedings of the National Academy of Sciences 115 (48), E11341-E11348, 2018 | 73 | 2018 |
| Antigen phagocytosis by B cells is required for a potent humoral response A Martínez‐Riaño, ER Bovolenta, P Mendoza, CL Oeste, ... EMBO reports 19 (9), e46016, 2018 | 57 | 2018 |
| First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases A Borroto, D Reyes-Garau, MA Jiménez, E Carrasco, B Moreno, ... Science translational medicine 8 (370), 370ra184-370ra184, 2016 | 54 | 2016 |
| R-Ras2 is required for germinal center formation to aid B cells during energetically demanding processes P Mendoza, N Martínez-Martín, ER Bovolenta, D Reyes-Garau, ... Science signaling 11 (532), eaal1506, 2018 | 30 | 2018 |
| Neutralizing activity of broadly neutralizing anti-HIV-1 antibodies against primary African isolates JCC Lorenzi, P Mendoza, YZ Cohen, L Nogueira, C Lavine, J Sapiente, ... Journal of virology 95 (5), 10.1128/jvi. 01909-20, 2021 | 20 | 2021 |
| Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia AM Hortal, CL Oeste, C Cifuentes, M Alcoceba, I Fernández-Pisonero, ... Molecular cancer 21 (1), 35, 2022 | 15 | 2022 |
| COVID-19 antibody development fueled by HIV-1 broadly neutralizing antibody research P Mendoza, JCC Lorenzi, C Gaebler Current Opinion in HIV and AIDS 16 (1), 25-35, 2021 | 10 | 2021 |
| Recreation of an antigen-driven germinal center in vitro by providing B cells with phagocytic antigen A Martínez-Riaño, P Delgado, R Tercero, S Barrero, P Mendoza, ... Communications Biology 6 (1), 437, 2023 | 1 | 2023 |
| Evolution of Antibody Immunity to SARS-CoV-2 (preprint) C Gaebler, Z Wang, JCC Lorenzi, F Muecksch, S Finkin, M Tokuyama, ... | 1 | 2020 |
| Analysis of HIV-1 latent reservoir and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117 YZ Cohen, JCC Lorenzi, L Krassnig, JP Barton, L Burke, J Pai, CL Lu, ... bioRxiv, 324509, 2018 | 1 | 2018 |
